Jazz Pharmaceuticals And Zymeworks Announce Jazz Has Confirmed Opt-In And Advances Partnership For Zanidatamab
MarketScreener,
(Nasdaq: JAZZ) and (Nasdaq: ZYME) today announced that Jazz has exercised its option to continue with its exclusive development…